Key result
Prehospital pharmacological interventions, including aspirin, glyceryl trinitrate, and morphine, are reviewed for their role in the early evidence-based management of acute coronary syndrome.
Why the study?
Acute coronary syndrome is a leading cause of mortality requiring prompt prehospital intervention, where paramedics play a key role in early recognition, pharmacological management, and risk-stratification.
This review outlines the pathophysiology and evidence-based prehospital pharmacological management of acute coronary syndrome, emphasizing the role of early paramedic intervention.
Answers are grounded in this paper and cite their sources.
May guide prehospital ACS protocols; leaves open optimal regimens pending prospective validation.
Acute coronary syndrome (ACS) is a leading cause of mortality, requiring prompt prehospital intervention. Paramedics play a key role in early recognition, pharmacological management, and risk-stratification. ACS results from myocardial ischaemia caused by atherosclerotic plaque rupture, presenting as ST elevation myocardial infarction, non-ST elevation myocardial infarction, or unstable angina. Key prehospital treatments include aspirin, glyceryl trinitrate, and morphine. Additional considerations include dual antiplatelet therapy for reperfusion, fibrinolysis when primary percutaneous coronary intervention is unavailable, selective oxygen therapy, and anti-emetics. This article reviews ACS pathophysiology and evidence-based pharmacological management in prehospital care.
No takes yet. Share an insight, caveat, or question.
Carl A Webster (2025) conducted a review in Acute coronary syndrome. Prehospital pharmacological interventions was evaluated. Prehospital pharmacological interventions, including aspirin, glyceryl trinitrate, and morphine, are reviewed for their role in the early evidence-based management of acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: